Proteomic profiling and ROC analysis identify CD151 and ELAVL1 as potential therapy response markers for the antiviral drug in resistant TNBC
Article in Life Sciences (March 2023)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead
Article in Frontiers in Oncology (August 2021)
Humanized Mice Are Instrumental to the Study of Plasmodium falciparum Infection
Article in Frontiers in Immunology (December 2018)